Literature DB >> 2177580

Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.

M Heinrichs1, W Baumgärtner, C C Capen.   

Abstract

Adenomas of the pars intermedia from 19 horses and normal pituitary glands from seven horses were evaluated histologically and immunocytochemically for adrenocorticotropic hormone (ACTH), alpha-melanocyte-stimulating hormone (alpha-MSH), beta-endorphin (beta-END), proopiomelanocortin (POMC), prolactin, neuron specific enolase, and glial fibrillary acidic protein (GFAP). The 26 horses ranged in age from 7 to 31 years. Histologically, all adenomas had a uniform pattern characterized by cords of large columnar cells forming palisades and pseudoacini separated by a delicate fibrovascular stroma. Immunostaining of adenomas derived from the pars intermedia was similar to that of non-neoplastic equine pars intermedia. An immunocytochemical evaluation revealed a diffuse, strong cytoplasmic reaction for POMC, a moderate to strong reaction for alpha-MSH and beta-END, a weak reaction for ACTH, and negative immunostaining for prolactin, GFAP, and neuron specific enolase in the adenomas. The unique clinicopathologic syndrome that develops in horses with pituitary adenomas appears to be the result of an over-production of POMC-derived peptides in addition to space-occupying effects resulting in dysfunction of the hypothalamus and neurohypophysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177580     DOI: 10.1177/030098589902700606

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  10 in total

1.  Longitudinal and cross-sectional studies to evaluate the risk of sarcoid associated with castration.

Authors:  S W Reid; H O Mohammed
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

2.  Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.

Authors:  Ricardo V Lloyd; Constance J D'Amato; Michelle T Thiny; Long Jin; Samuel P Hicks; William F Chandler
Journal:  Endocr Pathol       Date:  1993-06       Impact factor: 3.943

3.  A case report of feline pituitary carcinoma with hypercortisolism.

Authors:  Kazunori Kimitsuki; Hassadin Boonsriroj; Daisuke Kojima; Chun-Ho Park
Journal:  J Vet Med Sci       Date:  2013-09-10       Impact factor: 1.267

4.  Pituitary pars intermedia dysfunction (equine Cushing's disease) in a Thoroughbred stallion: a single report.

Authors:  Takashi Hatazoe; Hiroaki Kawaguchi; Seiji Hobo; Kazuhiro Misumi
Journal:  J Equine Sci       Date:  2016-02-03

5.  Spontaneous malignant craniopharyngioma in an aged Wistar rat.

Authors:  Martin Heinrichs; Heinrich Ernst
Journal:  J Toxicol Pathol       Date:  2016-05-31       Impact factor: 1.628

6.  Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.

Authors:  Heidrun Gehlen; Bianca Schwarz; Claus Bartmann; Jennifer Gernhardt; Sabita D Stöckle
Journal:  Animals (Basel)       Date:  2020-12-08       Impact factor: 2.752

7.  Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership.

Authors:  Rebecca C Tatum; Cathy M McGowan; Rachel S Dean; Joanne L Ireland
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

8.  Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy.

Authors:  Jessica S Fortin; Ashley A Hetak; Kelsey E Duggan; Caroline M Burglass; Hailey B Penticoff; Harold C Schott
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

9.  Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.

Authors:  Jessica S Fortin; Matthew J Benskey; Keith J Lookingland; Jon S Patterson; Erin B Howey; John L Goudreau; Harold C Schott
Journal:  BMC Vet Res       Date:  2020-09-25       Impact factor: 2.741

10.  Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction.

Authors:  Ruth A Morgan; John A Keen; Natalie Homer; Mark Nixon; Anna M McKinnon-Garvin; Jodie A Moses-Williams; Sarah R Davis; Patrick W F Hadoke; Brian R Walker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.